adriamycin is a brand family of Pharmaco, sold in Nepal. The NepalDoc catalog lists 2 adriamycin products, all Doxorubicin Hydrochloride.
Doxorubicin Hydrochloride Injection is an anthracycline topoisomerase inhibitor indicated: as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer, for the treatment of: acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms' tumor, metastatic neuroblastoma…
From the U.S. FDA-approved label for Doxorubicin Hydrochloride. Full label: DailyMed.
Doxorubicin Hydrochloride Injection is an anthracycline topoisomerase inhibitor indicated: as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer, for the treatment of: acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms' tumor, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma 1.1 Adjuvant Breast Cancer Doxorubicin Hydrochloride Injection is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer.
From the U.S. FDA-approved label for Doxorubicin Hydrochloride. Full label: DailyMed.
Single agent: 60 to 75 mg/m 2 given intravenously every 21 days, In combination: 40 to 75 mg/m 2 given intravenously every 21 to 28 days, Discontinue Doxorubicin Hydrochloride Injection in patients who develop signs or symptoms of cardiomyopathy, Reduce dose in patients with hepatic impairment 2.1 Recommended Dosage for Adjuvant Breast Cancer The recommended dosage of Doxorubicin Hydrochloride Injection is 60 mg/m 2 administered as an intravenous bolus on day 1 of each 21-day treatment cycle, in combination with cyclophosphamide, for a total of four cycles.
Directions from the U.S. FDA-approved label for Doxorubicin Hydrochloride — your doctor or pharmacist may advise differently.
Doxorubicin Hydrochloride Injection are contraindicated in patients with: Severe myocardial insufficiency, Recent (occurring within the past 4–6 weeks) myocardial infarction, Severe persistent drug-induced myelosuppression, Severe hepatic impairment (defined as Child Pugh Class C or serum bilirubin level greater than 5 mg/dL), Severe hypersensitivity reaction to doxorubicin hydrochloride, including anaphylaxis, Severe myocardial insufficiency, Recent myocardial infarction, Severe persistent drug-induced myelosuppression, Severe hepatic impairment, Severe hypersensitivity to doxorubicin hydrochloride
Excerpt from the U.S. FDA-approved label for Doxorubicin Hydrochloride. Talk to a pharmacist or doctor before use.
Radiation-Induced Toxicity: Can be increased by the administration of Doxorubicin Hydrochloride Injection. Radiation recall can occur in patients who receive Doxorubicin Hydrochloride Injection after prior radiation therapy., Embryo-Fetal Toxicity: Can cause fetal harm. Advise females of reproductive potential of the potential risk to a fetus and on the use of effective contraception. Advise males with female partners of reproductive potential to use effective contraception. Advise males with pregnant partners to use condoms.
Warnings and precautions excerpt from the U.S. FDA-approved label for Doxorubicin Hydrochloride — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described elsewhere in the labeling., Cardiomyopathy and Arrhythmias, Secondary Malignancies, Extravasation and Tissue Necrosis, Severe Myelosuppression, Tumor Lysis Syndrome, Radiation Sensitization and Radiation Recall The most common (>10%) adverse reactions are alopecia, nausea and vomiting. To report SUSPECTED ADVERSE REACTIONS, contact Pfizer, Inc.
Excerpt from the U.S. FDA-approved label for Doxorubicin Hydrochloride — not a complete list. Talk to a pharmacist or doctor about side effects.
7 brands · 4 makers in the NepalDoc catalog — see the full Doxorubicin Hydrochloride guide →
Store all vials at 2°C to 8°C (36°F to 46°F). Protect from light. Storage of Doxorubicin Hydrochloride Injection under refrigerated conditions can result in the formation of a gelled product. Place gelled product at room temperature for 2 to 4 hours to return the product to a slightly viscous, mobile solution.
Storage information from the U.S. FDA-approved label for Doxorubicin Hydrochloride.
What is adriamycin 50?
adriamycin 50mg Injection is a Doxorubicin Hydrochloride medicine made by Pharmaco. It comes as 50mg Injection.
What is the generic name of adriamycin 50?
The generic name of adriamycin 50 is Doxorubicin Hydrochloride.
Which brands of Doxorubicin Hydrochloride are available in Nepal?
7 brands of Doxorubicin Hydrochloride are listed in the NepalDoc catalog, from 4 makers — including Adriamycin 50mg Injection, adriamycin 10mg Injection, Adrim 10mg Injection, Adrim 50mg Injection, Doxoruba 10mg Injection, Doxoruba 50mg Injection.
What are the side effects of Doxorubicin Hydrochloride?
The following clinically significant adverse reactions are described elsewhere in the labeling., Cardiomyopathy and Arrhythmias, Secondary Malignancies, Extravasation and Tissue Necrosis, Severe Myelosuppression, Tumor Lysis Syndrome, Radiation Sensitization and Radiation Recall The most common (>10%) adverse reactions are alopecia, nausea and vomiting.
What is the price of adriamycin 50 in Nepal?
NepalDoc does not list medicine prices. Prices are set by individual pharmacies in Nepal and change over time — this page confirms the brand sold in Nepal, its generic name, maker, strength and pack details so you can check the price at your pharmacy with confidence.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.